Clinical trial
The Use of Ivermectin In the Treatment of COVID 19 Patients
NCT04425707 is registered in ClinicalTrials.gov with Ministry of Health and Population, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Ivermectin In the Treatment of COVID 19 Patients
- Lead sponsor
- Ministry of Health and Population, Egypt
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 9, 2020
- Completion date
- September 1, 2020
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19